Display options
Cite
XDx, Inc. Per Med. 2008;5(4):335-338doi: 10.2217/17410541.5.4.335.
(2008). XDx, Inc. Personalized medicine, 5(4), 335-338. https://doi.org/10.2217/17410541.5.4.335
"XDx, Inc." Personalized medicine vol. 5,4 (2008): 335-338. doi: https://doi.org/10.2217/17410541.5.4.335
XDx, Inc. Per Med. 2008 Jul;5(4):335-338. doi: 10.2217/17410541.5.4.335. PMID: 29783462.
Copy Download .nbib Format: NLM
Share it on

Per Med. 2008 Jul;5(4):335-338. doi: 10.2217/17410541.5.4.335.

XDx, Inc.

Personalized medicine

[No authors listed]

PMID: 29783462 DOI: 10.2217/17410541.5.4.335

Abstract

XDx, Inc. is a molecular diagnostics company focused on the discovery, development and commercialization of noninvasive gene expression-based tests for the monitoring of transplant rejection and autoimmune diseases. The company has developed a proprietary new method for noninvasively monitoring immune system activity by measuring gene expression in a patient's peripheral blood. This work is the basis for AlloMap

Publication Types